NEUROFARMACOLOGIA DEL DOLOR
NEUDOL
Johns Hopkins University School of Medicine
Baltimore, Estados UnidosPublicaciones en colaboración con investigadores/as de Johns Hopkins University School of Medicine (2)
2022
-
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
Science Translational Medicine, Vol. 14, Núm. 660
2019
-
Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury
Cell, Vol. 176, Núm. 4, pp. 716-728.e18